AN2 Therapeutics Statistics
Total Valuation
ANTX has a market cap or net worth of $41.84 million. The enterprise value is -$41.78 million.
Important Dates
The last earnings date was Tuesday, March 25, 2025, after market close.
Earnings Date | Mar 25, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ANTX has 30.10 million shares outstanding. The number of shares has increased by 26.39% in one year.
Current Share Class | 30.10M |
Shares Outstanding | 30.10M |
Shares Change (YoY) | +26.39% |
Shares Change (QoQ) | +0.14% |
Owned by Insiders (%) | 6.49% |
Owned by Institutions (%) | 33.36% |
Float | 17.73M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.51 |
P/TBV Ratio | 0.51 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.43
Current Ratio | 8.43 |
Quick Ratio | 8.20 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -49.69% and return on invested capital (ROIC) is -33.02%.
Return on Equity (ROE) | -49.69% |
Return on Assets (ROA) | -29.54% |
Return on Invested Capital (ROIC) | -33.02% |
Return on Capital Employed (ROCE) | -66.65% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.25M |
Employee Count | 41 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.83% in the last 52 weeks. The beta is 0.14, so ANTX's price volatility has been lower than the market average.
Beta (5Y) | 0.14 |
52-Week Price Change | -56.83% |
50-Day Moving Average | 1.25 |
200-Day Moving Average | 1.45 |
Relative Strength Index (RSI) | 54.55 |
Average Volume (20 Days) | 121,912 |
Short Selling Information
The latest short interest is 71,203, so 0.24% of the outstanding shares have been sold short.
Short Interest | 71,203 |
Short Previous Month | 112,040 |
Short % of Shares Out | 0.24% |
Short % of Float | 0.40% |
Short Ratio (days to cover) | 0.45 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -54.55M |
Pretax Income | -66.03M |
Net Income | -51.32M |
EBITDA | n/a |
EBIT | -54.55M |
Earnings Per Share (EPS) | -$1.72 |
Full Income Statement Balance Sheet
The company has $83.62 million in cash and n/a in debt, giving a net cash position of $83.62 million or $2.78 per share.
Cash & Cash Equivalents | 83.62M |
Total Debt | n/a |
Net Cash | 83.62M |
Net Cash Per Share | $2.78 |
Equity (Book Value) | 81.85M |
Book Value Per Share | 2.74 |
Working Capital | 76.02M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -49.26M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |